Dr. Anahita Dua

Dr. Dua is an Associate Professor of Surgery at the Massachusetts General Hospital/Harvard Medical School. She is the director of the peripheral artery disease center, associate director of the wound center, clinical director of research and director of the sub-internship in vascular surgery. She is the past director of the vascular lab at the MGH. She developed and currently leads the Limb Evaluation and Amputation Program (LEAP) at the MGH. She also founded and runs the only comprehensive vascular surgery homeless clinic in the country at the MGH.


Dr. Dua completed her vascular surgery fellowship at Stanford University Hospital, general surgery residency at the Medical College of Wisconsin and her medical school in the United Kingdom. She has also completed a master's degree (MS) in trauma sciences and a master's in business administration (MBA) in health care management. She also has a certificate in health economics and outcomes research as well certificates in drug and device development and Artificial Intelligence (AI) in healthcare from the Massachusetts Institute of Technology (MIT). Dr. Dua is doubled board-certified in vascular surgery and general surgery. She is also boarded in advanced wound care and management. Dr. Dua has published over 250 peer reviewed papers and has edited five vascular surgery medical textbooks. She serves on multiple national vascular surgery committees including the Society for Vascular Surgery, is the past president of the South Asian-American Vascular Society (SAAVS) and the current president of the Society for Vascular Ultrasound (SVU) Foundation. She is a past presidential leadership scholar.


Dr. Dua runs an NIH funded lab that focuses on anticoagulation and biomarkers that are predictive of thrombosis and hemostasis in patients that have undergone revascularization. Her research focuses on thromboprophylaxis precision and point of care medical approaches to anticoagulation for patients post revascularization. Her clinical and outcomes research focuses primarily on diseases involving peripheral vascular disease, limb salvage and critical limb ischemia. She is part of a technology development team that creates tools to increase walking distance and wound healing while decreasing pain in patients with peripheral vascular disease.